1. Nagai H, Kim YH (2017) Cancer prevention from the perspective of global cancer burden patterns. J. Thorac. Dis.
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. https://doi.org/10.3322/caac.21660
3. Yu Y, Ramena G, Elble RC (2012) The role of cancer stem cells in relapse of solid tumors. Front. Biosci. - Elit.
4. Elbaiomy MA, Akl T, Atwan N, Elsayed AA, Elzaafarany M, Shamaa S (2020) Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients. J Oncol 2020: . https://doi.org/10.1155/2020/2561726
5. Deng X, Xu G, He L, Xu M (2017) p75NTR promotes survival of breast cancer resistant cells by regulating Bcl-2/Bax and MAPK pathway. Int J Clin Exp Pathol 10:11685–11694
6. Tomellini E, Lagadec C, Polakowska R, Le Bourhis X (2014) Role of p75 neurotrophin receptor in stem cell biology: More than just a marker. Cell. Mol. Life Sci.
7. Bhakar AL, Howell JL, Paul CE, Salehi AH, Becker EBE, Said F, Bonni A, Barker PA (2003) Apoptosis Induced by p75NTR Overexpression Requires Jun Kinase-Dependent Phosphorylation of Bad. J Neurosci. https://doi.org/10.1523/jneurosci.23-36-11373.2003
8. Filipp F V., Li C, Boiko AD (2019) CD271 is a molecular switch with divergent roles in melanoma and melanocyte development. Sci Rep. https://doi.org/10.1038/s41598-019-42773-y
9. Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H (2001) Nerve Growth Factor Stimulates Proliferation and Survival of Human Breast Cancer Cells through Two Distinct Signaling Pathways. J Biol Chem. https://doi.org/10.1074/jbc.M010499200
10. Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A (2006) Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue. Mod Pathol 19:307–319 . https://doi.org/10.1038/modpathol.3800542
11. Khwaja F, Tabassum A, Allen J, Djakiew D (2006) The p75NTR tumor suppressor induces cell cycle arrest facilitating caspase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun. https://doi.org/10.1016/j.bbrc.2006.01.073
12. Tabassum A, Khwaja F, Djakiew D (2003) The p75NTR tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int J Cancer. https://doi.org/10.1002/ijc.11038
13. Jin H, Pan Y, Zhao L, Zhai H, Li X, Sun L, He L, Chen Y, Hong L, Du Y, Fan D (2007) p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia. https://doi.org/10.1593/neo.07175
14. Yuanlong H, Haifeng J, Xiaoyin Z, Jialin S, Jie L, Li Y, Huahong X, Jiugang S, Yanglin P, Kaichun W, Jie D, Daiming F (2008) The inhibitory effect of p75 neurotrophin receptor on growth of human hepatocellular carcinoma cells. Cancer Lett. https://doi.org/10.1016/j.canlet.2008.03.038
15. Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M (2006) The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. Hum Pathol. https://doi.org/10.1016/j.humpath.2005.12.016
16. Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, Pincelli C (2008) The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma. J Invest Dermatol. https://doi.org/10.1038/jid.2008.21
17. Betters E, Liu Y, Kjaeldgaard A, Sundström E, García-Castro MI (2010) Analysis of early human neural crest development. Dev Biol. https://doi.org/10.1016/j.ydbio.2010.05.012
18. Tomellini E, Touil Y, Lagadec C, Julien S, Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E, Polakowska R, Le Bourhis X (2015) Nerve growth factor and prongf simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment. Stem Cells. https://doi.org/10.1002/stem.1849
19. Okumura T, Shimada Y, Imamura M, Yasumoto S (2003) Neurotrophin receptor p75NTR characterizes human esophageal keratinocyte stem cells in vitro. Oncogene. https://doi.org/10.1038/sj.onc.1206525
20. Di Girolamo N, Sarris M, Chui J, Cheema H, Coroneo MT, Wakefield D (2008) Localization of the low-affinity nerve growth factor receptor p75 in human limbal epithelial cells. J Cell Mol Med. https://doi.org/10.1111/j.1582-4934.2008.00290.x
21. Li X, Shen Y, Di B, Li J, Geng J, Lu X, He Z (2012) Biological and clinical significance of p75 NTR expression in laryngeal squamous epithelia and laryngocarcinoma. Acta Otolaryngol. https://doi.org/10.3109/00016489.2011.639086
22. Tsang JYS, Wong KHY, Lai MWH, Lacambra MD, Ko CW, Chan SK, Lam CCF, Yu AMC, Tan PH, Tse GM (2013) Nerve growth factor receptor (NGFR): A potential marker for specific molecular subtypes of breast cancer. J Clin Pathol 66:291–296 . https://doi.org/10.1136/jclinpath-2012-201027
23. Aragona M, Panetta S, Silipigni AM, Romeo DL, Pastura G, Mesiti M, Cascinu S, La Torre F (2001) Nerve growth factor receptor immunoreactivity in breast cancer patients. Cancer Invest 19:692–697 . https://doi.org/10.1081/CNV-100106144
24. Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduct. Target. Ther.
25. Dolle L, Adriaenssens E, Yazidi-Belkoura I, Bourhis X, Nurcombe V, Hondermarck H (2005) Nerve Growth Factor Receptors and Signaling in Breast Cancer. Curr Cancer Drug Targets. https://doi.org/10.2174/1568009043332853
26. Xia Y, Shen S, Verma IM (2014) NF-κB, an active player in human cancers. Cancer Immunol. Res.
27. Pratt MAC, Tibbo E, Robertson SJ, Jansson D, Hurst K, Perez-Iratxeta C, Lau R, Niu MY (2009) The canonical NF-B pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene. https://doi.org/10.1038/onc.2009.131
28. Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, Tian Y, Liu L, Su M, Wang H, Cao D, Liao Q (2018) Role of the NFκB-signaling pathway in cancer. Onco Targets Ther. https://doi.org/10.2147/OTT.S161109
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. https://doi.org/10.1006/meth.2001.1262
30. Kikin O, D’Antonio L, Bagga PS (2006) QGRS Mapper: A web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res. https://doi.org/10.1093/nar/gkl253
31. Kreft L, Soete A, Hulpiau P, Botzki A, Saeys Y, De Bleser P (2017) ConTra v3: A tool to identify transcription factor binding sites across species, update 2017. Nucleic Acids Res. https://doi.org/10.1093/nar/gkx376
32. Mochizuki M, Tamai K, Imai T, Sugawara S, Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, Motohashi H, Sugamura K, Tanaka N (2016) CD271 regulates the proliferation and motility of hypopharyngeal cancer cells. Sci Rep. https://doi.org/10.1038/srep30707
33. Huang MC, Chu I Te, Wang ZF, Lin S, Chang TC, Chen CT (2018) A g-quadruplex structure in the promoter region of CLIC4 functions as a regulatory element for gene expression. Int J Mol Sci. https://doi.org/10.3390/ijms19092678
34. Oeckinghaus A, Ghosh S (2009) The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol.
35. Khan MA, Tania M, Fu S, Fu J (2017) Thymoquinone, as an anticancer molecule: From basic research to clinical investigation. Oncotarget
36. Dastjerdi MN, Mehdiabady EM, Iranpour FG, Bahramian H (2016) Effect of thymoquinone on P53 gene expression and consequence apoptosis in breast cancer cell line. Int J Prev Med. https://doi.org/10.4103/2008-7802.180412
37. Ayob AZ, Ramasamy TS (2018) Cancer stem cells as key drivers of tumour progression. J. Biomed. Sci.
38. Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, Van Den Broek M, Sommer L (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-10-3997
39. Li S, Yue D, Chen X, Wang L, Li J, Ping Y, Gao Q, Wang D, Zhang T, Li F, Yang L, Huang L, Zhang Y (2015) Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity. Oncol Rep. https://doi.org/10.3892/or.2014.3569
40. Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB (2018) CD271 confers an invasive and metastatic phenotype of head and neck squamous cell carcinoma through the upregulation of slug. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-0866
41. Elkashty OA, Elghanam GA, Su X, Liu Y, Chauvin PJ, Tran SD (2020) Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Carcinogenesis. https://doi.org/10.1093/carcin/bgz182
42. Redmer T, Welte Y, Behrens D, Fichtner I, Przybilla D, Wruck W, Yaspo ML, Lehrach H, Schäfer R, Regenbrecht CRA (2014) The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS One. https://doi.org/10.1371/journal.pone.0092596
43. Gündüz UR, Gunaldi M, Isiksacan N, Gündüz S, Okuturlar Y, Kocoglu H (2016) A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Mol Clin Oncol. https://doi.org/10.3892/mco.2016.919
44. Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M (2003) CD24 Expression Is a New Prognostic Marker in Breast Cancer. Clin Cancer Res
45. Kwon MJ, Han J, Seo JH, Song K, Jeong HM, Choi JS, Kim YJ, Lee SH, Choi Y La, Shin YK (2015) CD24 overexpression is associated with poor prognosis in luminal a and triple-negative breast cancer. PLoS One. https://doi.org/10.1371/journal.pone.0139112
46. Kanyilmaz G, Benli Yavuz B, Aktan M, Karaagac M, Uyar M, Findik S (2019) Prognostic Importance of Ki-67 in Breast Cancer and Its Relationship with Other Prognostic Factors. Eur J Breast Heal. https://doi.org/10.5152/ejbh.2019.4778
47. Liang L, Coudiere-Morrison L, Tatari N, Stromecki M, Fresnoza A, Porter CJ, Del Bigio MR, Hawkins C, Chan JA, Ryken TC, Taylor MD, Ramaswamy V, Werbowetski-Ogilvie TE (2018) CD271þ cells are diagnostic and prognostic and exhibit elevated mapk activity in SHH medulloblastoma. Cancer Res. https://doi.org/10.1158/0008-5472.CAN-18-0027
48. Sethi G, Kwang SA, Aggarwal BB (2008) Targeting nuclear factor-κB activation pathway by thymoquinone: Role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res. https://doi.org/10.1158/1541-7786.MCR-07-2088
49. Salem AA, El Haty IA, Abdou IM, Mu Y (2015) Interaction of human telomeric G-quadruplex DNA with thymoquinone: A possible mechanism for thymoquinone anticancer effect. Biochim Biophys Acta - Gen Subj. https://doi.org/10.1016/j.bbagen.2014.10.018